Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Silicon Laboratories    SLAB

Delayed Quote. Delayed  - 05/27 09:59:59 pm
49.36 USD   +1.38%
05/25 SILICON LABORAT : Mentor Graphics Analog FastSPICE(TM) Platform Sele..
04/27 SILICON LABORAT : Labs beats Street 1Q forecasts
04/27 SILICON LABS : Announces First Quarter 2016 Results
Analysis summary4-Traders Strategies 

Silicon Laboratories : USD 49.9 as next target price

share with twitter share with LinkedIn share with facebook
share via e-mail
02/13/2013 | 03:25pm
Opinion : Bullish above USD 42.7
Target price : USD 49.9
Stop loss: USD 40.5

The company shows strong fundamentals. Firstly, the high valuation of the group shows a great investors confidence in it because there are ready to pay a high price for the stock. Moreover, the consensus recently revised upward EPS estimates for this year and that let see a great potential for the security on the stock market.

From a technical viewpoint, the security is trading in a bullish trend in the short and the long term. Increasing moving averages let think there will be no reversal in the coming trading sessions. This growth should help to reach soon the USD 49.9 long term resistance.

A new bullish fluctuation could lead the security toward the USD 49.9 resistance. In consequence, investors can take a long position in Silicon Laboratories. A stop loss will be set under the short term support at USD 42.7.

Silicon Laboratories : Silicon Laboratories : USD 49.9 as next target price

© Zonebourse.com 2013

share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and 4-traders.com services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.

Financial Ratios

Size 2016e 2017e
Capitalization 2 061 M$ -
Entreprise Value (EV) 2 240 M$ 2 222 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 52,6x 36,3x
Capitalization / Revenue 3,03x 2,84x
EV / Revenue 3,29x 3,06x
EV / EBITDA 16,1x 15,2x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,57x 2,32x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 17,4% 17,9%
operating Leverage (Delta EBIT / Delta Sales) 1,52x 1,46x
Net Margin (Net Profit / Revenue) 5,86% 8,02%
ROA (Net Profit / Asset) 10,1% 10,9%
ROE (Net Profit / Equities) 13,4% 10,6%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   1,57% 1,49%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 0,58x 0,74x
Financial Leverage (Net Debt / EBITDA) 1,28x 1,11x
Income Statement Evolution
More Financials
EPS Revisions